Yalcin, A. D. Et Al. 2012. Total Antioxidant Capacity, Hydrogen Peroxide, Malondialdehyde and Total Nitric Oxide Concentrations in Patients with Severe Persistent Allergic Asthma: Its Relation To Omalizumab Treatment. CLINICAL LABORATORY , vol.58 , 89-96.

Yalcin, A. D., Gorczynski, R. M., Parlak, G. E., Kargi, A., Bisgin, A., Sahin, E., ... Kose, S.(2012). Total Antioxidant Capacity, Hydrogen Peroxide, Malondialdehyde and Total Nitric Oxide Concentrations in Patients with Severe Persistent Allergic Asthma: Its Relation To Omalizumab Treatment. CLINICAL LABORATORY , vol.58, 89-96.

Yalcin, Arzu Et Al. "Total Antioxidant Capacity, Hydrogen Peroxide, Malondialdehyde and Total Nitric Oxide Concentrations in Patients with Severe Persistent Allergic Asthma: Its Relation To Omalizumab Treatment," CLINICAL LABORATORY , vol.58, 89-96, 2012

Yalcin, Arzu D. Et Al. "Total Antioxidant Capacity, Hydrogen Peroxide, Malondialdehyde and Total Nitric Oxide Concentrations in Patients with Severe Persistent Allergic Asthma: Its Relation To Omalizumab Treatment." CLINICAL LABORATORY , vol.58, pp.89-96, 2012

Yalcin, A. D. Et Al. (2012) . "Total Antioxidant Capacity, Hydrogen Peroxide, Malondialdehyde and Total Nitric Oxide Concentrations in Patients with Severe Persistent Allergic Asthma: Its Relation To Omalizumab Treatment." CLINICAL LABORATORY , vol.58, pp.89-96.

@article{article, author={Arzu Didem Yalcin Et Al. }, title={Total Antioxidant Capacity, Hydrogen Peroxide, Malondialdehyde and Total Nitric Oxide Concentrations in Patients with Severe Persistent Allergic Asthma: Its Relation To Omalizumab Treatment}, journal={CLINICAL LABORATORY}, year=2012, pages={89-96} }